chrisvoncsefalvay/vaers-outcomes huggingface dataset:
It started with severe fatigue, muscle aches & pain. High blood pressure started about 10 days after getting vaccine and peaked at 185/117. At this point I called my doctor and started blood pressure medication, amlodipine.  I then noticed heart rhythm issue and rapid pulse rate and went to cardiologist.
I had a sore throat, more lethargic than normal, low-grade fever, felt like maybe I had not had enough sleep. I took a home COVID-19 test that came back positive. I called the doctor, had a telehealth visit to discuss my symptoms and positive test. I was prescribed PAXLOVID antiviral that knocked the virus out of my body.
this case reference number 2000006648-1, is a spontaneous report from a physician referring to a 16 year old male patient. Follow up information from the patient's mother was forwarded by a pharmacist. The patient has a history of environmental allergies and has a history of asthma. On 11/18/99, the patient received his first injection of Engerix-B at an unspecified dose for Prophylaxis, with no untoward effects. On 12/24/99, he received the second dose and afterward experienced headache and dizziness. On 02/07/00, the boy received the third injection of Engerix-B while the symptoms were ongoing. Follow up information from the pharmacist reveals, the child has severe migraine headaches, and severe vertigo. Also, he experienced elevated systolic blood pressure running 170-175 and loss of appetite. The other reported to the pharmacist, her son her son has not been in school for two months. The migraine headaches and vertigo (dizziness) have been deemed serious as the patient missed school and thus are incapacitating. The information received on 03/08/00 reports the symptoms are ongoing.
he got a rash on both of his arms on day 2 and it lasted until day 5 after that first COVID vaccine; This is a spontaneous report from a non-contactable Other HCP. This Other HCP reporting for a 72-year-old male patient received a dose of vaccine BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EN6205) via an unspecified route of administration on an unspecified date (at the age of 72 years) as an 1st dose single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient reported at his second COVID vaccine appointment that after his first COVID vaccine, he got a rash on both of his arms on day 2 (on unknown date) and it lasted until day 5 after that first COVID vaccine. Outcome of the event was resolved.  No follow up attempts are possible. No further information is expected.
pt recv vax & was not right for 1 week afterwards per mom- cried, high fever 102, only took grape juice for 1 wk nothing else;
After I received the vaccine it started to hurt and it has never gone away. I saw the doctor recently because I was taking Tylenol and it wasn't working. The doctor said I have tinnitus and has started me on physical therapy.
Pt was diagnosed with COVID in the ER on 12/15 and placed on Paxlovid. Arrived to the ED today due to altered mental status and bradycardia. Admitted due to previous and COVID-19 as well as dehydration.
c/o persistent headache, abd pain, low appetite, and L leg on/off pain since J&J vaccine on 5 Apr. denies n/v/d/, chest pain or sob. states BP is higher then usual. concerns for blood clot. last Tylenol 1000.  51 yo f c/o MEG pain/'knot' w/ongoing decreased appetite and nausea w/o vomiting x7d w/additional new ha w/o visual changes x2-3d approx 10d s/p J&J covid vaccine; Pt states concerns for ulcer vs. other etiology; Pt denies any fevers/ns/chills, urinary sx's, back pain, vaginal bleeding/discharge, recent hx of trauma/inj  distant hx of 1x hysterectomy
Had injection in upper left arm,under that arm My lymph notes stayed swollen for about a week.. the next Monday swelling went down alot almost gone,now I would say it's back to normal maybe maybe alittle still..
Follow up provided information regarding serotyping. Information regarding Prevnar was received from a healthcare professional regarding a 3 year old male who experienced pneumococcal meningitis. At 11 months of age, the patient received the fourth dose on 1/28/02. The patient had no relevant medical history. Indication for Prevnar was immunization. Product was administered on 1/28/02. Dose regimen was 1 dose (IM). Concomitant therapy included Varivax. In October 2004, the patient was hospitalized for pneumococcal meningitis. An unspecified culture revealed streptococcus pneumoniae. The patient was discharged after 5 days and continued treatment with Rocephin for a total of 14 days. The patient recovered. The reporter indicated that there is no information pertaining to the serotype of streptococcus pneumoniae in the patient's chart. The reporter did not believe serotyping was performed. The reporter considered this event to be life-threatening.
6 x 4.5 cm area erythema, swelling, rash, warmth at vaccination site.  Temperature 98.  Seen by doctor at clinic on 07/2/08 for cellulitis right arm vaccination site.  Treated with Amoxicillin 250mg 1 cap 3 times/day for 7 days.
After my second Covid19 vaccine shot I developed symptoms such as headache, back aches, a rash, and fatigue.      This started at 6 am the next morning after the vaccine, and lasted for 24 hours. Except the headache which lasted about 48 hours.      Rash is going away, but still itchy on bottom half of body.
Was accidentally given a different second dose for the COVID-19 vaccine than the first dose by the nurse.
10cm painful, erythematous cellulitis surrounding site of the injection 48 hours after receiving Adacel. Temp 98.1, Progressive gradual swelling involving left shoulder, supra clavicles and lateral neck areas. Administered Benadryl 81 mg IM x 1 and Solu Medrol 40 mg IM x 1, started on Keflex 500 mg TID x 7 days.
Information has been received from a physician concerning a 58 year old white male who on Jul 08 2004 was vaccinated with a second dose of pneumococcal 23v polysaccharide vaccine (lot 646322/0530N), in the left arm, Subsequently the patient developed a red, hot, swollen and tender upper arm. Subsequently, the patient recovered. Additional information has been requested.
Called patient and they are feeling fine. Patient should not have received 2nd booster of Moderna since they are not 50 years old and are not immunocompromised.
dad states pt was playing became very quiet; had strange look on face became stiff lasted a few seconds; states felt warm; didn't take temp; encouraged father to have pt checked by MD:
- THINK JUST STRONG IMMUNE RESPONSE: - Headache, dizzy, nauseated, weak, Pelvic pain - Enlarged lymph node on Ipsilalent side of shot - Concentration off BLOOD SUGARS SLIGHT Elevation (129-132 fasting) Decrease in Blood Pressure to 104/76 (usually 120s to 130s/80s
On 11/14/2021 started complaining of lower right quadrant pain that got worse as the day went on and was not managed with ibuprofen or Tylenol. Eventually he could not stand up from a seated position without assistance or yelling in pain.  On 11/26/2021, he was admitted for a post-appendectomy abscess and is still being treated.
Redness at injection site; Swollen at injection site; Itching at injection site; This is a spontaneous report received from a contactable consumer, the patient. A 55-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205) via an unspecified route of administration at right arm on 08Mar2021 at 09:15 (age of 55-year-old at vaccination), as single dose for COVID-19 immunisation. The patient medical history included common variable immune deficiency. Concomitant medications included LO LOESTRIN FE, magnesium (MANUFACTURER UNKNOWN), Vitamin C (MANUFACTURER UNKNOWN), fish oil (MANUFACTURER UNKNOWN), Vitamin B12 (MANUFACTURER UNKNOWN), Vitamin D (MANUFACTURER UNKNOWN) for unspecified indication and from unknown start date. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Mar2021 at 10:00, the patient experienced redness, swollen and itching at injection site. A little swelling but no pain. The patient did not receive any treatment for events. The clinical outcome of event redness at injection site, swollen at injection site and itching at injection site were recovered.   No follow-up attempts are needed. No further information is expected.
Sore arm at 3hrs; headache, stiff neck, woozy at 8hrs (took Ibuprofen) restless night's sleep at 15hrs, body aches, mild nausea at 22hrs, headache, lethargy at 25hrs (took Ibuprofen), symptoms getting better since 25hrs (currently 32hrs).
Client called clinic and complained of developed fine, red, small in appearance rash from lower abdomen up to chest only. Afebrile and no other complaints. Rash develop.
Drug ineffective; had COVID-19 virus; A patient (no qualifiers provided) received COVID-19 Vaccine - Manufacturer Unknown, as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown"; COVID-19 (medically significant), outcome "unknown", described as "had COVID-19 virus". Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: A patient that had COVID-19 virus and took the Paxlovid and finished the course already about 2 days ago and now they were asking if that patient can take the booster (Pfizer COVID-19 booster shot) (event captured as per verbatim) or that patient needs to wait for a period of time.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: As there is limited information in the case provided, the causal association between the events Drug ineffective and Covid-19 and the suspect drug cannot be excluded. The case will be reassessed once new information is available.
Fever, sore edematous arm on 4/16/2003. To PMD on 4/17/03, received 2 "antibiotic" injections, continue Motrin every 6 hours, moist heat. 4/23/03: completely recovered.
1 in pink ring around the bruise - this continued until it reached 2 in ring and then stopped; Grape-size bruise with a tail; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE BRUISING (Grape-size bruise with a tail) and VACCINATION SITE ERYTHEMA (1 in pink ring around the bruise - this continued until it reached 2 in ring and then stopped) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021 at 3:45 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE BRUISING (Grape-size bruise with a tail). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (1 in pink ring around the bruise - this continued until it reached 2 in ring and then stopped). At the time of the report, VACCINATION SITE BRUISING (Grape-size bruise with a tail) and VACCINATION SITE ERYTHEMA (1 in pink ring around the bruise - this continued until it reached 2 in ring and then stopped) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Treatment information was provided.  No concomitant medications were included.   Reporter did not allow further contact
headache; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot number: EK5730), via an unspecified route of administration on 26Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got the Covid vaccine on 26Dec2020. The patient's daughter has like a fever yesterday with headache. The patient thinks his/her daughter has Covid and was just tested yesterday, so they still do not have results. Today (01Jan2021) the patient woke up with a headache, a different headache than which he/she usually has, but he/she does not have fever. The patient is not sure if she should report this, but he/she was told to report anything to the Pfizer company. The patient asked if he/she should be tested for Covid as well. The outcome of the event was unknown.
Information has been received from a nurse referring to an unknown number of patients of unknown age and gender. Patients' concurrent conditions, concomitant medication and medical history were not provided. On unknown date (s), three doses of improperly stored MMR II (lot#, dose, route and dose number were not provided) might have been administered to patients. No adverse events were reported. Additional information has been requested.
Pt tested positive for COVID-19 as part of routine screening for a procedure at a local hospital on 4/7/2021.  Pt began to have symptoms and was given monoclonal antibodies near where she lives on 4/12/2021.  Symptoms grew worse overnight and she was admitted to her local hospital on 4/13/2021 with acute hypoxic respiratory failure and started on O2.  O2 demands continued to increase during the day and she was transferred to our ICU.  Currently on high flow nasal canula, but not intubated.
This case was reported by a pharmacist and described the occurrence of injection site pain in a 67-year-old subject of unspecified gender who was vaccinated with BOOSTRIX. On an unspecified date the subject received unspecified dose of BOOSTRIX (.5 ml, unknown, right arm). Approximately three to four days after vaccination with BOOSTRIX, the subject experienced pain and swelling at injection site. Pharmacist stated that the subject reported feeling pain and swelling at the injection site three to four days after the BOOSTRIX injection. Six to seven days after, the subject is complaining of more pain/increased with intensity with some swelling near the injection site (slightly below the injection site). At the time of the report no other information was available. At the time of reporting the pain and swelling at injection site were worse.
Light red/pink round rash on upper arm near injection site with darker red/pink edges. Slightly itchy
I had shingles covering my upper back, near my shoulder blade. It started March 19th, one week after I received my COVID shot, within one week the lesions were healed.
Severe pain at injection site, hard lump at injection site, crying, then had seizures. EMS was called. I hadn't had seizures in months so I doubt this was a coincidence. Still in pain 2 days later despite taking Tylenol.
1/2 hr p/vax pt returned & gen raised red rash noted over body, most prominently on arms & legs;no rash noted in mouth nor any swelling noted in throat;
20apr90 pt vax hepta B. 21apr90 pt dvel faint rash on face, neck and back. md attrib. sx to vax.  18may90 pt vax 2nd hepta B. 4 hrs later pt ex. 1 hive on forehead, 1 possible hive on leg and pain at inject site.
This spontaneous reports as received from a registered nurse refers to a unspecified number of patients. Reporter stated she had no patient data available. On an unknown date the patients were vaccinated with LIQUID PEDVAXHIB, 0.5 ml, (dose unspecified in series), intramuscularly. Lot number or expiry data were not available (no dates were expired). On unknown dates the patients received doses of LIQUID PEDVAXHIB which were exposed to 9C degree for 360 hours. No adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report as received from a healthcare worker concerning an unknown number of patients of an unknown age and gender. Medical history and concurrent conditions were not reported. On an unknown date the patients were vaccinated with a dose of RECOMBIVAX HB (dose, frequency, strength, lot number, expiration date and route were not reported). Co-suspect and concomitant therapies were not reported. The healthcare worker reported that on an unknown date, an improperly stored RECOMBIVAX HB may have all been administered. The healthcare worker that she would call back once she knows for sure which vaccines had been administered. The healthcare worker reported that the RECOMBIVAX HB was exposed to a temperature of 1.5C for 25 minutes. NO adverse effect reported. Additional information has been requested. This is one (1) of five (5) reports from the same reporter. (MARRS 1405USA012173, 1406USA000568, 1406USA000569, 1406USA000570 and 1406USA000571).
On the 11th of December I was aboard a cruise, and I wasn't feeling good so I took a rapid COVID19 test in my cabin and tested positive.  I went down to the infirmary and they performed a PCR test that came back positive for COVID. They gave me Paxlovid for 5 days and an 10 day antibiotic, and sent me to my room for Isolation. On the 13th I took a rapid test in my cabin and it came back negative but I had to stay in my cabin. I had a bit of a sore throat, a little cough, and just general feverish and achiness, and very tired and fatigued.
Shots given @ 10AM had dec activity, low grade fever approx 8 hrs post vax; pt had unusual cry & went limp-lasted 1-2 minutes; no cyanosis;
After about 13 days I developed a bald spot on the left side of my head.  It appears the hair follicles are dead.  It has been over a month since this first appeared with no evidence that it is getting better.
I started progressive tremor in both hands, unable to write especially in the morning, difficulty to write this report, jerkiness/chorea/ in both hands and left leg, occasionally in Rt leg. Also chorea  involving my head and face a week following . Left leg cramps at night and foggy thinking during entire days,  extreme progressive tiredness , irritable. My symptoms continue. At the beginning I thought symptoms will go away so I waited patiently hoping to see improvement. Today I will be seeing my internist and follow up with his recommendation. MD, retired surgeon
After Flumist vaccination, pt developed low grade fever x 3 weeks, swollen lymph nodes x 1 week, developed congestion and cough x 3 weeks and headaches.  Patient had nausea and vomiting x 1 week. Pt missed total of about 6 days of work.
Swelling of the hands and lips, treated with Benadryl by next morning swelling had decreased some. By day 2 all of swelling had resolved
Immediately after shot, fast heartrate; Feel tingling in arm and hand of injection; This is a spontaneous report from a contactable consumer (patient). A 37-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Batch/Lot number: EN6201, expiration date: 30Jun2021) via an unspecified route of administration, administered in Arm Right on 17Feb2021 at 14:00(age at vaccination 37-year-old) as dose 1 single for COVID-19 immunization. Medical history included ankylosing spondylitis, Thalassaemia (Verbatim reported as Thamlesemia). Concomitant medication(s) included meloxicam 15mg (MOBIC), ascorbic acid, borago officinalis oil, fish oil, magnesium, nicotinamide, pyridoxine, zinc 1280mg (OMEGA- 3), vitamin d3 1,000 i.u (MANUFACTURE UNKNOWN) received within 2 weeks of vaccination. The Patient did not receive any other vaccines within 4 weeks Prior to vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. Consumer stated that When his first got COVID-19 Vaccine on 17Feb2021. Immediately after shot he had a fast heartrate, and it was up in the 90 for heartrate for about 5 or so hours. Then that went away, and his heartrate began to become normal on 17Feb2021 and he also has tingling in arm and hand and his wondering if you can tell me if it was something that was being reported and if there was anything, he can do about it. The patient stated that he wants Should his take the second shot. The patient just need to know if it is going to be systemic if it is temporary and if anyone has been reporting this before or if it is common. The patient did not receive any treatment for the events. The outcome of the events Immediately after shot, fast heartrate was recovered on 17Feb2021 and Feel tingling in arm and hand of injection was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
sweating; vomiting; bacteria in her intestines; This is a spontaneous report from a contactable consumer.   A 94-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as as single dose, for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The reported stated that on Tuesday after receiving the shot, her grandmother, who is usually sitting in a wheelchair, was leaning forward while seated and began sweating  "sweating a lot in head and in her hair and then started vomiting" on an unspecified date. The patient was transported to the ER by ambulance for evaluation but was later sent home, they found that she had a bacteria in her intestines. Outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Pt began to feel unwell on 5/7. Presented to emergency room on 5/9. Pt admitted and given oxygen, remdesivir and convalescent plasma. Pt still admitted.
This spontaneous report as received from a pharmacist refers to multiple patients of unknown age and gender. There were no concomitant medications, concurrent conditions and medical history reported. On an unknown date, the patients were vaccinated with doses of improperly stored PNEUMOVAX 23 lot # K021030, expiration date: 22-JUN-2016 (dose, route and site of administration were not reported). No adverse effects were reported. Follow up information has been received from the pharmacist on 09-NOV-2015. On 12-SEP-2015, the patient was vaccinated with dose of improperly stored PNEUMOVAX 23. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested. Patient details, suspect therapy, event data and narrative were updated.
Presente to the Medical Clinic on 3/18/08 with c/o rash times 2-3 days. MD evaluated and noted maculopapular lesions 20-30 on back and abdomen and carbuncle to the occipital ridge posterior scalp. Diagnosed with dermatitis probably rash due to smallpox reaction per MD and carbuncle. Given Cephalexin and Benadryl. RTC if worse.
Swelling/hives on  left arm, left hand, and right hand.  Tingling/swelling lips and lump in throat.
Client received insufficient dose. Client was a staff nurse working at out Reach clinic.  Was due to get her second dose of Moderna, asked another staff nurse to administer it for her. The providing staff nurse requested a booster dose from the pharmacy, instead of the required 0.5 ML dose. So only half of the required those was administered.  This was at the end of the clinic, both staff nurses had left work by the time error was discovered during vaccine inventory report. The patient was contacted, offered the option of returning to receive the second dose after consultation with health department personnel. Client declined, was informed she could not receive it in the future, and advised to speak to her doctor and to obtain booster dose as soon as eligible
TINNITUS, which began as a continuous, low-pitched water-flowing sound. Awakened today, 10/07/2023, by a continuous, high-pitched ringing of the same intensity in both years, associated with slight VERTIGO. )I'm experiencing some associated hearing loss.) Neither symptom has been experienced since I was exposed to a loud noise about 30 years ago.